BRISTOL-MYERS SQUIBB COMPANY Amortization of Intangible Assets
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Amortization of Intangible Assets of $471.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for the quarter ending 2026-06-30 was $471.00M, a 45.49% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for the quarter ending 2026-03-31 was $472.00M, a 45.31% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for the quarter ending 2025-12-31 was $900.00M, a 47.06% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for the quarter ending 2025-09-30 was $867.00M, a 63.87% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for fiscal 2025 was $3.50B, a 61.11% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for fiscal 2024 was $9.00B, a 2.17% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for fiscal 2023 was $9.20B, a 5.15% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY amortization of intangible assets for fiscal 2022 was $9.70B, a 4.90% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $471.00M 10-Q · filed 2026-07-30 | $943.00M 10-Q · filed 2026-07-30 | $1.84B derived: sum of 3 quarters · filed 2026-07-30 | $2.71B derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $472.00M 10-Q · filed 2026-04-30 | $1.37B derived: sum of 2 quarters · filed 2026-04-30 | $2.24B derived: sum of 3 quarters · filed 2026-04-30 | $3.10B derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $900.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.77B derived: sum of 2 quarters · filed 2026-02-11 | $2.63B derived: sum of 3 quarters · filed 2026-07-30 | $3.50B 10-K · filed 2026-02-11 | ||
| 2025-09-30 | $867.00M 10-Q · filed 2025-10-30 | $1.73B derived: sum of 2 quarters · filed 2026-07-30 | $2.60B 10-Q · filed 2025-10-30 | $4.29B derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $864.00M 10-Q · filed 2026-07-30 | $1.70B 10-Q · filed 2026-07-30 | $3.43B derived: sum of 3 quarters · filed 2026-07-30 | $5.83B derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $863.00M 10-Q · filed 2026-04-30 | $2.56B derived: sum of 2 quarters · filed 2026-04-30 | $4.96B derived: sum of 3 quarters · filed 2026-04-30 | $7.36B derived: sum of 4 quarters · filed 2026-04-30 | ||
| 2024-12-31 | $1.70B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.10B derived: sum of 2 quarters · filed 2026-02-11 | $6.50B derived: sum of 3 quarters · filed 2026-02-11 | $9.00B 10-K · filed 2026-02-11 | ||
| 2024-09-30 | $2.40B 10-Q · filed 2025-10-30 | $4.80B derived: sum of 2 quarters · filed 2025-10-30 | $7.30B 10-Q · filed 2025-10-30 | $9.50B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-06-30 | $2.40B 10-Q · filed 2025-07-31 | $4.80B 10-Q · filed 2025-07-31 | $7.10B derived: sum of 3 quarters · filed 2026-02-11 | $9.40B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2024-03-31 | $2.40B 10-Q · filed 2025-04-24 | $4.70B derived: sum of 2 quarters · filed 2026-02-11 | $7.00B derived: sum of 3 quarters · filed 2026-02-11 | $9.30B derived: sum of 4 quarters · filed 2026-02-11 | ||
| 2023-12-31 | $2.30B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $4.60B derived: sum of 2 quarters · filed 2026-02-11 | $6.90B derived: sum of 3 quarters · filed 2026-02-11 | $9.20B 10-K · filed 2026-02-11 | ||
| 2023-09-30 | $2.30B 10-Q · filed 2024-10-31 | $4.60B derived: sum of 2 quarters · filed 2024-10-31 | $6.90B 10-Q · filed 2024-10-31 | $9.20B derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $2.30B 10-Q · filed 2024-07-26 | $4.60B 10-Q · filed 2024-07-26 | $6.90B derived: sum of 3 quarters · filed 2025-02-12 | $9.40B derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-03-31 | $2.30B 10-Q · filed 2024-04-25 | $4.60B derived: sum of 2 quarters · filed 2025-02-12 | $7.10B derived: sum of 3 quarters · filed 2025-02-12 | $9.50B derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2022-12-31 | $2.30B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $4.80B derived: sum of 2 quarters · filed 2025-02-12 | $7.20B derived: sum of 3 quarters · filed 2025-02-12 | $9.70B 10-K · filed 2025-02-12 | ||
| 2022-09-30 | $2.50B 10-Q · filed 2023-10-26 | $4.90B derived: sum of 2 quarters · filed 2023-10-26 | $7.40B 10-Q · filed 2023-10-26 | $9.90B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $2.40B 10-Q · filed 2023-07-27 | $4.90M 10-Q · filed 2023-07-27 | $4.90B 10-Q · filed 2022-07-27 | $7.40B derived: sum of 3 quarters · filed 2024-02-13 | $10.00B derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-03-31 | $2.50B 10-Q · filed 2023-04-27 | $5.00B derived: sum of 2 quarters · filed 2024-02-13 | $7.60B derived: sum of 3 quarters · filed 2024-02-13 | $10.10B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $2.50B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $5.10B derived: sum of 2 quarters · filed 2024-02-13 | $7.60B derived: sum of 3 quarters · filed 2024-02-13 | $10.20B 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $2.60B 10-Q · filed 2022-10-26 | $5.10B derived: sum of 2 quarters · filed 2022-10-26 | $7.70B 10-Q · filed 2022-10-26 | $10.30B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $2.50B 10-Q · filed 2022-07-27 | $5.10B 10-Q · filed 2022-07-27 | $7.70B derived: sum of 3 quarters · filed 2023-02-14 | $10.20B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $2.60B 10-Q · filed 2022-04-29 | $5.20B derived: sum of 2 quarters · filed 2023-02-14 | $7.70B derived: sum of 3 quarters · filed 2023-02-14 | $10.20B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $2.60B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $5.10B derived: sum of 2 quarters · filed 2023-02-14 | $7.60B derived: sum of 3 quarters · filed 2023-02-14 | $9.90B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $2.50B 10-Q · filed 2021-10-27 | $5.00B derived: sum of 2 quarters · filed 2021-10-27 | $7.30B 10-Q · filed 2021-10-27 | $8.44B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-06-30 | $2.50B 10-Q · filed 2021-07-28 | $4.80B 10-Q · filed 2021-07-28 | $5.94B derived: sum of 3 quarters · filed 2022-02-09 | $6.00B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2020-03-31 | $2.30B 10-Q · filed 2021-04-29 | $3.44B derived: sum of 2 quarters · filed 2022-02-09 | $3.50B derived: sum of 3 quarters · filed 2022-02-09 | $3.55B derived: sum of 4 quarters · filed 2022-02-09 | ||
| 2019-12-31 | $1.14B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $1.20B derived: sum of 2 quarters · filed 2022-02-09 | $1.25B derived: sum of 3 quarters · filed 2022-02-09 | $1.30B 10-K · filed 2022-02-09 | $1.25B 10-K · filed 2020-02-24 | |
| 2019-09-30 | $52.00M 10-Q · filed 2020-11-05 | $103.00M derived: sum of 2 quarters · filed 2020-11-05 | $156.00M 10-Q · filed 2020-11-05 | $207.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $51.00M 10-Q · filed 2020-08-06 | $104.00M 10-Q · filed 2020-08-06 | $155.00M derived: sum of 3 quarters · filed 2021-02-10 | $209.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | $53.00M 10-Q · filed 2020-05-07 | $104.00M derived: sum of 2 quarters · filed 2021-02-10 | $158.00M derived: sum of 3 quarters · filed 2021-02-10 | $205.00M derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $105.00M derived: sum of 2 quarters · filed 2021-02-10 | $152.00M derived: sum of 3 quarters · filed 2021-02-10 | $198.00M 10-K · filed 2021-02-10 | ||
| 2018-09-30 | $54.00M 10-Q · filed 2019-10-31 | $101.00M derived: sum of 2 quarters · filed 2019-10-31 | $147.00M 10-Q · filed 2019-10-31 | $195.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-06-30 | $47.00M 10-Q · filed 2019-07-25 | $93.00M 10-Q · filed 2019-07-25 | $141.00M derived: sum of 3 quarters · filed 2020-02-24 | $189.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $46.00M 10-Q · filed 2019-04-25 | $94.00M derived: sum of 2 quarters · filed 2020-02-24 | $142.00M derived: sum of 3 quarters · filed 2020-02-24 | $189.00M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2017-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $96.00M derived: sum of 2 quarters · filed 2020-02-24 | $143.00M derived: sum of 3 quarters · filed 2020-02-24 | $190.00M 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $95.00M derived: sum of 2 quarters · filed 2018-10-25 | $142.00M 10-Q · filed 2018-10-25 | $186.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-06-30 | $47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $94.00M 10-Q · filed 2018-07-26 | $138.00M derived: sum of 3 quarters · filed 2019-02-25 | $184.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2017-03-31 | $47.00M 10-Q · filed 2018-04-26 | $91.00M derived: sum of 2 quarters · filed 2019-02-25 | $137.00M derived: sum of 3 quarters · filed 2019-02-25 | $181.00M derived: sum of 4 quarters · filed 2019-02-25 | ||
| 2016-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $90.00M derived: sum of 2 quarters · filed 2019-02-25 | $134.00M derived: sum of 3 quarters · filed 2019-02-25 | $178.00M 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $46.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $90.00M derived: sum of 2 quarters · filed 2017-10-26 | $134.00M 10-Q · filed 2017-10-26 | $177.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | $44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $88.00M 10-Q · filed 2017-07-27 | $131.00M derived: sum of 3 quarters · filed 2018-02-13 | $175.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | $44.00M 10-Q · filed 2017-04-27 | $87.00M derived: sum of 2 quarters · filed 2018-02-13 | $131.00M derived: sum of 3 quarters · filed 2018-02-13 | $175.00M derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $87.00M derived: sum of 2 quarters · filed 2018-02-13 | $131.00M derived: sum of 3 quarters · filed 2018-02-13 | $183.00M 10-K · filed 2018-02-13 | ||
| 2015-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $88.00M derived: sum of 2 quarters · filed 2016-10-27 | $140.00M 10-Q · filed 2016-10-27 | $204.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | $44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $96.00M 10-Q · filed 2016-07-28 | $160.00M derived: sum of 3 quarters · filed 2017-02-21 | $231.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-03-31 | $52.00M 10-Q · filed 2016-04-28 | $116.00M derived: sum of 2 quarters · filed 2017-02-21 | $187.00M derived: sum of 3 quarters · filed 2017-02-21 | $259.00M derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2014-12-31 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $135.00M derived: sum of 2 quarters · filed 2017-02-21 | $207.00M derived: sum of 3 quarters · filed 2017-02-21 | $286.00M 10-K · filed 2017-02-21 | ||
| 2014-09-30 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $143.00M derived: sum of 2 quarters · filed 2015-10-27 | $222.00M 10-Q · filed 2015-10-27 | $433.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-30 | $72.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-23 | $151.00M 10-Q · filed 2015-07-23 | $362.00M derived: sum of 3 quarters · filed 2016-02-12 | $578.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-31 | $79.00M 10-Q · filed 2015-04-28 | $290.00M derived: sum of 2 quarters · filed 2016-02-12 | $506.00M derived: sum of 3 quarters · filed 2016-02-12 | $721.00M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-31 | $211.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $427.00M derived: sum of 2 quarters · filed 2016-02-12 | $642.00M derived: sum of 3 quarters · filed 2016-02-12 | $858.00M 10-K · filed 2016-02-12 | ||
| 2013-09-30 | $216.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $431.00M derived: sum of 2 quarters · filed 2014-10-24 | $647.00M 10-Q · filed 2014-10-24 | $860.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | $215.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $431.00M 10-Q · filed 2014-07-24 | $644.00M derived: sum of 3 quarters · filed 2015-02-13 | $835.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-03-31 | $216.00M 10-Q · filed 2013-04-25 | $429.00M derived: sum of 2 quarters · filed 2015-02-13 | $620.00M derived: sum of 3 quarters · filed 2015-02-13 | $722.00M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2012-12-31 | $213.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $404.00M derived: sum of 2 quarters · filed 2015-02-13 | $506.00M derived: sum of 3 quarters · filed 2015-02-13 | $607.00M 10-K · filed 2015-02-13 | ||
| 2012-09-30 | $191.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | $293.00M derived: sum of 2 quarters · filed 2013-10-23 | $394.00M 10-Q · filed 2013-10-23 | $486.00M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-06-30 | $102.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $203.00M 10-Q · filed 2013-07-25 | $295.00M derived: sum of 3 quarters · filed 2014-02-14 | |||
| 2012-03-31 | $101.00M 10-Q · filed 2013-04-25 | $193.00M derived: sum of 2 quarters · filed 2014-02-14 | ||||
| 2011-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $353.00M 10-K · filed 2014-02-14 | -$271.00M 10-K · filed 2012-02-17 | |||
| 2011-09-30 | $261.00M 10-Q · filed 2012-10-24 | |||||
| 2010-12-31 | $271.00M 10-K · filed 2013-02-15 | -$199.00M 10-K · filed 2012-02-17 | ||||
| 2009-12-31 | -$170.00M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |